Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news round-up: Sirius Minerals, Green Dragon Gas, Reneuron ...

A glance at some of the stories on the Proactive newswire today

Sirius Minerals PLC (LON:SXX) has seen another 30 of its stage one financing convertible bonds converted into equity.

The convertible bonds, due 2023, were issued at US$200,000 each and raised US$400mln. This latest conversion means that US$19.8mln of the bonds issued have been converted into shares.

Shares in the York Potash fertiliser project developer jumped 7% to 34.5p.

Green Dragon Gas Ltd (LON:GDG) has received 100% acceptances of the requested waivers of its financial covenants for the US$88mln senior secured bonds with Nordic Trustee.

The bond trustee has also agreed the release of the non-core downstream operational assets, which will conclude the evolution of Green Dragon Gas into a pure upstream business.

Chariot Oil & Gas Limited (LON:CHAR) trundled higher as it identified five new structural prospects offshore Namibia.

The shares advanced 7% to 14.5p after 3D seismic on Namibian blocks 2312 and 2412A identified similar geology to nearby successful wells.

“These prospects have the potential for material accumulations and success in one will significantly de-risk the remainder,” said Larry Bottomley, chief executive.

ReNeuron Group Plc (LON:RENE) has received positive guidance from US regulator as it prepares to take its CTX cell therapy candidate for stroke victims into final-stage clinical trials.

Following “favourable feedback” from come from US regulator the Food & Drug Administration, which has suggested the company apply for a Special Protocol Assessment (SPA) for the phase III study, potentially shortening the time to market.

Med-tech firm ANGLE PLC (LON:AGL) has uncovered another potential use of its liquid biopsy system after finding success in isolating and identifying tell-tale signs of breast, head and neck cancers. The results of a study to be presented to the prestigious American Society of Clinical Oncology in Chicago point to a potential use in the colorectal cancer.

ITM Power plc (LON:ITM) has £23.02mln of projects under contract, with a further £4.16mln of contracts waiting for sign-off, constituting a pipeline of £27.18mln, up £2.82mln since 18 April.

Waste-to-energy specialist PowerHouse Energy Group PLC (LON:PHE) has secured funding from a “large corporate partner” which has committed up to £500,000 to the AIM-quoted group. Subject to achieving certain performance milestones with its G3-UHt demonstration unit, PowerHouse will receive the cash in two tranches.

Berkeley Energia (LON:BKY) has commenced the search for Zona 7 lookalikes on its Salamanca uranium project in Spain. An extensive sampling programme will be undertaken to identify drill targets

Petropavlovsk PLC (LON:POG) has highlighted that IRC, in which it holds a 31% stake, is ramping up production at its Russian iron ore assets, and may bring a second project on stream if commodities prices remain firm.

Richland Resources Limited (LON:RLD) has cut costs and boosted revenues following a second year of production from its sapphire mines in Queensland Australia.

Westminster Group PLC (LON:WSG) said the recovery in West Africa airport passenger numbers is continuing as it confirmed a return to underlying profitability in 2016.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK